In this review, we focus on and discuss the role of the NLRP3 inflammasome in cardiovascular diseases induced by radiotherapy and how its modulation could represent a potential therapeutic target to improve cancer survivors’ quality of life. The gene discussed is NLRP3; the disease is cardiovascular disorder.